Now in its 10th successful year, Strategic Research Institute’s “Antibacterial Drug Discovery & Development Summit” has established itself as the must-attend industrial science and networking event.

The meeting is distinguished by its focus on cutting-edge, industrial efforts and its intimate, friendly format. You will have plenty of opportunity to participate in the excellent networking and business development opportunities at the meeting, interacting with the finest scientists in the world anti-infective community.

Celebrating 10 Years as the Premier Industry-Focused Anti-Microbial Drug Discovery & Development Meeting Place

Conference Chairpersons:

John F. Barrett, Ph.D.
Senior Director, Anti-Infectives
MERCK & CO.

Michael J. Pucci, Ph.D.
Director, Antimicrobial Drug Discovery
ACHILLION PHARMACEUTICALS

Special Interactive Panel Discussion Added for 2005!

Why Are Smaller Biopharmaceutical Companies Entering the Antibacterial Fray While Big Pharma Is Still Leaving?

Moderators:

John F. Barrett, Ph.D.
Senior Director, Anti-Infectives
MERCK & CO.

Michael J. Pucci, Ph.D.
Director, Antimicrobial Drug Discovery
ACHILLION PHARMACEUTICALS

Panelists:

Henry F. Chambers, M.D.
Professor of Medicine
UNIVERSITY OF CALIFORNIA AT SAN FRANCISCO

Lynn L. Silver, Ph.D.
Independent Consultant
LL SILVER CONSULTING

Matthew A. Wikler, M.D., MBA, FIDSA
Chief Medical Officer & Executive Vice President
PENINSULA PHARMACEUTICALS (invited)

Thomas D. Gootz, Ph.D.
Research Fellow
PFIZER GLOBAL R&D

Arnoud J. Dijkstra, Ph.D.
Director, Business Development
ACETLION PHARMACEUTICALS